No connection

Search Results

Analysis Neutral

December 2027 Options Now Available For Neurocrine Biosciences (NBIX)

Apr 07, 2026 15:33 UTC

Investors in Neurocrine Biosciences, Inc. (Symbol: NBIX) saw new options become available today, for the December 2027 expiration.

  • April 07, 2026 — 11:33 am EDT Written byBNK InvestforBNK Invest-> The put contract at the $130
  • 00 strike price has a current bid of $16
  • 90

April 07, 2026 — 11:33 am EDT Written byBNK InvestforBNK Invest-> The put contract at the $130.00 strike price has a current bid of $16.90. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $130.00, but will also collect the premium, putting the cost basis of the shares at $113.10 (before broker commissions). To an investor already interested in purchasing shares of NBIX, that could represent an attractive alternative to paying $132.55/share today. Because the $130.00 strike represents an approximate 2% discount to the current trading price of t

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile